| Net Cash Provided by (Used in) Operating Activities |
$4,174,000,000 |
USD |
14% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$10,422,000,000 |
USD |
1,809% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$-297,000,000 |
USD |
36% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
4,320,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
3,119,843,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$14,369,000,000 |
USD |
298% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$18,231,000,000 |
USD |
-8.75% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,638,000,000 |
USD |
43% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$16,826,000,000 |
USD |
22% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$1,200,000,000 |
USD |
9.1% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$795,000,000 |
USD |
-1.49% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$4,220,000,000 |
USD |
196% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$53,375,000,000 |
USD |
8.3% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$2,172,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$2,298,000,000 |
USD |
7.1% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
2,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$2,200,000,000 |
USD |
-8.33% |
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$4,500,000,000 |
USD |
-2.17% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$1,772,000,000 |
USD |
-2.37% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$15,188,000,000 |
USD |
20% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$715,000,000 |
USD |
50% |
Q1 2024 |
Q1 2024 |